Conectado por

Rondônia, sábado, 22 de janeiro de 2022.



English

Brazil receives request for emergency use of CanSino vaccine


Compartilhe:

Publicado por

em


Continua após a publicidade
Colégio Sapiens

Brazil’s national sanitary regulator Anvisa received the request for the authorization of the emergency use of a new vaccine against COVID-19. The inoculation comes from pharmaceutical company CanSino, based in China. The request was filed by the firm’s representative in Brazil, Biomm.

Called Convidecia, the inoculation includes just one shot, like the Janssen vaccine. Anvisa now has seven business days to issue a reply, which may be extended if the watchdog needs further clarifications or new information regarding the consortium of companies charged with the offer of the inoculation in Brazil.


Continua após a publicidade
Educa Mais Brasil

Anvisa’s team will evaluate the documents on the vaccine, which should provide details on security, efficiency, duration of protection, and immunogenicity.

According to the data bank on vaccines against COVID-19 from Canada’s McGill University, the CanSino vaccine has been approved in nine countries, most of them in Asia and Latin America.

Publicidade

educamaisbrasil educamaisbrasil

Últimas notícias

Facebook